X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8978) 8978
Publication (567) 567
Book Chapter (152) 152
Dissertation (122) 122
Conference Proceeding (92) 92
Book Review (87) 87
Book / eBook (9) 9
Web Resource (6) 6
Data Set (5) 5
Magazine Article (3) 3
Government Document (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4447) 4447
drug interactions (3423) 3423
pharmacology & pharmacy (3290) 3290
drug-drug interactions (2886) 2886
index medicus (2791) 2791
animals (2321) 2321
drug-drug interaction (2171) 2171
male (2167) 2167
pharmacokinetics (1540) 1540
female (1449) 1449
adult (974) 974
rats (923) 923
middle aged (862) 862
metabolism (820) 820
in-vitro (707) 707
receptors, drug - drug effects (670) 670
aged (634) 634
analysis (564) 564
drug–drug interaction (563) 563
pharmacology (559) 559
inhibition (537) 537
dose-response relationship, drug (536) 536
drugs (501) 501
mice (486) 486
toxicology (484) 484
drug–drug interactions (474) 474
p-glycoprotein (473) 473
kinetics (429) 429
cytochrome p450 (426) 426
drug interaction (406) 406
cytochrome p-450 enzyme system - metabolism (401) 401
cytochrome p-450 (397) 397
biochemistry & molecular biology (387) 387
young adult (380) 380
area under curve (375) 375
drug therapy, combination (361) 361
in vitro techniques (357) 357
pharmacology/toxicology (340) 340
research (339) 339
models, biological (336) 336
chemistry, multidisciplinary (326) 326
enzymes (317) 317
liver (316) 316
human liver-microsomes (310) 310
drug therapy (304) 304
adolescent (294) 294
prediction (290) 290
administration, oral (273) 273
rats, sprague-dawley (267) 267
therapy (265) 265
pharmacy (264) 264
cytochrome p-450 cyp3a - metabolism (260) 260
metabolites (259) 259
polypharmacy (254) 254
cross-over studies (249) 249
liver - metabolism (248) 248
cancer (246) 246
chemistry, medicinal (245) 245
cyp3a4 (245) 245
time factors (243) 243
pharmaceutical preparations - metabolism (242) 242
complications and side effects (240) 240
microsomes, liver - metabolism (240) 240
cells, cultured (237) 237
physiological aspects (237) 237
pharmacodynamics (232) 232
medicine & public health (229) 229
drug design (225) 225
oncology (222) 222
aged, 80 and over (221) 221
safety (219) 219
biomedicine (216) 216
protein binding (212) 212
article (210) 210
microsomes, liver - drug effects (210) 210
microsomes, liver - enzymology (210) 210
risk factors (210) 210
internal medicine (208) 208
enzyme inhibitors - pharmacology (207) 207
expression (204) 204
drug metabolism (201) 201
induction (200) 200
warfarin (193) 193
drug synergism (188) 188
dosage and administration (186) 186
risk (184) 184
care and treatment (180) 180
healthy-volunteers (180) 180
binding sites (174) 174
hiv (173) 173
absorption (172) 172
health aspects (172) 172
ketoconazole (171) 171
medicine (170) 170
cytochrome p-450 enzyme inhibitors (168) 168
hiv infections - drug therapy (168) 168
prevalence (168) 168
toxicity (168) 168
liver - drug effects (167) 167
hepatocytes - metabolism (166) 166
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5890) 5890
Japanese (1797) 1797
Chinese (1429) 1429
German (63) 63
French (42) 42
Russian (27) 27
Spanish (25) 25
Slovenian (10) 10
Czech (7) 7
Korean (6) 6
Portuguese (6) 6
Polish (5) 5
Hungarian (2) 2
Italian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Journal Article
Journal Article
by Qian, S and Liang, SQ and Yu, HY
PLOS COMPUTATIONAL BIOLOGY, ISSN 1553-7358, 05/2019, Volume 15, Issue 5, pp. e1007068 - e1007068
Journal Article
Journal Article